New CEO Named For Harvard Bioscience
A veteran executive of the life sciences industry has been named to the top position at Harvard Bioscience of Holliston.
Jeffrey A. Duchemin, who has served in executive-level roles with Corning Life Sciences and Becton Dickinson, was announced as the company’s CEO today. He will succeed David Green, who was filling in as interim CEO after Chane Graziano resigned following 17 years in the role. Green will continue as president of the maker of life sciences equipment.
Duchemin spent 16 years with Becton Dickinson (BD) in progressive sales, marketing and executive leadership positions across its three business segments: BD Medical Systems, BD Diagnostic Systems and BD Biosciences. In October 2012, BD Biosciences, Discovery Labware was acquired by Corning Life Sciences.
“I’m thrilled to join the Harvard Bioscience team and look forward to leading the company to increased shareholder value through acquisitions, greater growth in expanding foreign markets, enhanced sales and marketing efforts and continued internal product development," Duchemin said in a statement distributed by Harvard Bioscience.
“I have great confidence that Jeff can lead Harvard Bioscience to the next level of growth and value creation for all our shareholders," added Green, who helped found the company.
Duchemin earned an MBA from Southern New Hampshire University and a bachelor’s degree in accounting from the University of Massachusetts Dartmouth.
Read more
WBJ Web Partners
Most Recent
Most Recent
0 Comments